Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.

Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.

Mostrar outras versões (1)

There is a growing recognition of the importance of protein kinases in the control of alternative splicing. To define the underlying regulatory mechanisms, highly selective inhibitors are needed. Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a pote...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Fedorov, O, Huber, K, Eisenreich, A, Filippakopoulos, P, King, O, Bullock, A, Szklarczyk, D, Jensen, L, Fabbro, D, Trappe, J, Rauch, U, Bracher, F, Knapp, S
Formato:	Journal article
Idioma:	English
Publicado em:	2011

Registros relacionados

Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.
por: Fedorov, O, et al.
Publicado em: (2011)

7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.
por: Huber, K, et al.
Publicado em: (2012)

Regulation of influenza A virus mRNA splicing by CLK1
por: Artarini, A, et al.
Publicado em: (2019)

CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
por: Fernando Salvador, et al.
Publicado em: (2018-05-01)

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
por: Maya L Bulos, et al.
Publicado em: (2023-12-01)

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.
por: Bullock, A, et al.
Publicado em: (2009)

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation
por: Bullock, A, et al.
Publicado em: (2009)

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
por: Elizabeth Bowler, et al.
Publicado em: (2018-04-01)

Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
por: Debdab, M, et al.
Publicado em: (2011)

Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
por: Kenichi Iwai, et al.
Publicado em: (2018-05-01)

Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing.
por: Shinsuke Araki, et al.
Publicado em: (2015-01-01)

DFG-1 residue controls inhibitor binding mode and affinity, providing a basis for rational design of kinase inhibitor selectivity
por: Schröder, M, et al.
Publicado em: (2020)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
por: Filippakopoulos, P, et al.
Publicado em: (2012)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
por: Filippakopoulos, P, et al.
Publicado em: (2012)

Clk/STY (cdc2-like kinase 1) and Akt regulate alternative splicing and adipogenesis in 3T3-L1 pre-adipocytes.
por: Pengfei Li, et al.
Publicado em: (2013-01-01)

CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
por: Vincent Geoghegan, et al.
Publicado em: (2022-11-01)

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
por: Viet Hung Dao, et al.
Publicado em: (2021-10-01)

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression
por: Jasper Van Goubergen, et al.
Publicado em: (2025-02-01)

Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors.
por: Aiko Murai, et al.
Publicado em: (2020-01-01)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
por: Walter, A, et al.
Publicado em: (2018)

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency
por: Ahmed K. ElHady, et al.
Publicado em: (2021-02-01)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.
por: Anne Walter, et al.
Publicado em: (2018-01-01)

Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission.
por: Selina Kern, et al.
Publicado em: (2014-01-01)

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
por: Pogacic, V, et al.
Publicado em: (2007)

CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor
por: Tyler Funnell, et al.
Publicado em: (2017-02-01)

Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.
por: Shamila S Gunatilleke, et al.
Publicado em: (2012-01-01)

Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors
por: Joanne Tan, et al.
Publicado em: (2017-11-01)

CLK3 promotes tumor proliferation by activating MYC signaling
por: Jing Shen, et al.
Publicado em: (2024-09-01)

Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
por: Lori Ferrins, et al.
Publicado em: (2023-05-01)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
por: Popp, T, et al.
Publicado em: (2016)

CLK2 Condensates Reorganize Nuclear Speckles and Induce Intron Retention
por: Bing Wang, et al.
Publicado em: (2024-10-01)

Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors.
por: Christian Schmitt, et al.
Publicado em: (2014-01-01)

The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
por: Hay, D, et al.
Publicado em: (2013)

Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
por: Lori Ferrins, et al.
Publicado em: (2023-10-01)

Discrimination of fennel chemotypes applying IR and Raman spectroscopy – discovery of a new -asarone chemotype
por: Krähmer, Andrea, et al.
Publicado em: (2016-07-01)

Calculation of Splicing Potential from the Alternative Splicing Mutation Database
por: Afonin Kirill A, et al.
Publicado em: (2008-02-01)

Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
por: Rooney, T, et al.
Publicado em: (2012)

The Alternative Splicing Mutation Database: a hub for investigations of alternative splicing using mutational evidence
por: Afonin Kirill A, et al.
Publicado em: (2008-02-01)

Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency
por: Subha Dahal, et al.
Publicado em: (2022-08-01)

In depth investigation of the metabolism of Nectandra megapotamica chemotypes.
por: Katyuce de S Farias, et al.
Publicado em: (2018-01-01)